119 related articles for article (PubMed ID: 30391395)
1. Can urinary titin be used for predicting Duchenne muscular dystrophy?
Bai SM; Guo XX
Clin Chim Acta; 2019 Mar; 490():161. PubMed ID: 30391395
[No Abstract] [Full Text] [Related]
2. Can urinary titin be used for predicting Duchenne muscular dystrophy?
Matsuo M; Awano H; Nishio H
Clin Chim Acta; 2019 Mar; 490():162. PubMed ID: 30395868
[No Abstract] [Full Text] [Related]
3. Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients.
Awano H; Matsumoto M; Nagai M; Shirakawa T; Maruyama N; Iijima K; Nabeshima YI; Matsuo M
Clin Chim Acta; 2018 Jan; 476():111-116. PubMed ID: 29175173
[TBL] [Abstract][Full Text] [Related]
4. Receiver operating curve analyses of urinary titin of healthy 3-y-old children may be a noninvasive screening method for Duchenne muscular dystrophy.
Matsuo M; Shirakawa T; Awano H; Nishio H
Clin Chim Acta; 2018 Nov; 486():110-114. PubMed ID: 30053403
[TBL] [Abstract][Full Text] [Related]
5. Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy.
Rouillon J; Zocevic A; Leger T; Garcia C; Camadro JM; Udd B; Wong B; Servais L; Voit T; Svinartchouk F
Neuromuscul Disord; 2014 Jul; 24(7):563-73. PubMed ID: 24813925
[TBL] [Abstract][Full Text] [Related]
6. Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents.
Robertson AS; Majchrzak MJ; Smith CM; Gagnon RC; Devidze N; Banks GB; Little SC; Nabbie F; Bounous DI; DiPiero J; Jacobsen LK; Bristow LJ; Ahlijanian MK; Stimpson SA
Neuromuscul Disord; 2017 Jul; 27(7):635-645. PubMed ID: 28554556
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urine.
Maruyama N; Asai T; Abe C; Inada A; Kawauchi T; Miyashita K; Maeda M; Matsuo M; Nabeshima YI
Sci Rep; 2016 Dec; 6():39375. PubMed ID: 27991570
[TBL] [Abstract][Full Text] [Related]
8. Titin fragment in urine: A noninvasive biomarker of muscle degradation.
Matsuo M; Awano H; Maruyama N; Nishio H
Adv Clin Chem; 2019; 90():1-23. PubMed ID: 31122607
[TBL] [Abstract][Full Text] [Related]
9. Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy.
Sato T; Awano H; Ishiguro K; Shichiji M; Murakami T; Shirakawa T; Matsuo M; Nagata S; Ishigaki K
Neuromuscul Disord; 2021 Mar; 31(3):194-197. PubMed ID: 33563515
[TBL] [Abstract][Full Text] [Related]
10. Urinary N-terminal fragment of titin is a marker to diagnose muscular dystrophy in patients with cardiomyopathy.
Yoshihisa A; Kiko T; Sato T; Oikawa M; Kobayashi A; Takeishi Y
Clin Chim Acta; 2018 Sep; 484():226-230. PubMed ID: 29870683
[TBL] [Abstract][Full Text] [Related]
11. Missed opportunities for duchenne muscular dystrophy.
Kaufmann P
J Pediatr; 2009 Sep; 155(3):309-10. PubMed ID: 19732575
[No Abstract] [Full Text] [Related]
12. Duchenne muscular dystrophy: issues in expanding newborn screening.
Kemper AR; Wake MA
Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
[TBL] [Abstract][Full Text] [Related]
13. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
Wein N; Alfano L; Flanigan KM
Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
[TBL] [Abstract][Full Text] [Related]
14. CUGC for Duchenne muscular dystrophy (DMD).
Coote DJ; Davis MR; Cabrera M; Needham M; Laing NG; Nowak KJ
Eur J Hum Genet; 2018 May; 26(5):749-757. PubMed ID: 29330543
[No Abstract] [Full Text] [Related]
15. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
[TBL] [Abstract][Full Text] [Related]
16. Strong correlation between the 6-minute walk test and accelerometry functional outcomes in boys with Duchenne muscular dystrophy.
Davidson ZE; Ryan MM; Kornberg AJ; Walker KZ; Truby H
J Child Neurol; 2015 Mar; 30(3):357-63. PubMed ID: 24762862
[TBL] [Abstract][Full Text] [Related]
17. Muscular dystrophy: Are we looking for subtle signs?
Biswas A
Arch Dis Child; 2018 May; 103(5):522. PubMed ID: 29222177
[No Abstract] [Full Text] [Related]
18. Delayed diagnosis of Duchenne muscular dystrophy.
Mohamed K; Appleton R; Nicolaides P
Eur J Paediatr Neurol; 2000; 4(5):219-23. PubMed ID: 11030068
[TBL] [Abstract][Full Text] [Related]
19. [Genetic analysis and prenatal diagnosis of Duchenne or Becker muscular dystrophy].
Zhao W; Jiang N; Li S; Li JS; Miao Y; Liang SY; Yu DY
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):226-231. PubMed ID: 31006187
[No Abstract] [Full Text] [Related]
20. Precordial R wave height does not correlate with echocardiographic findings in boys with Duchenne muscular dystrophy.
Thrush PT; Edward N; Flanigan KM; Mendell JR; Allen HD
Congenit Heart Dis; 2013; 8(6):561-7. PubMed ID: 23510265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
